In the regulation (EU) 2017/746 on in vitro diagnostic medical devices published by the European Parliament and the Council, the rules regarding the placing of in-vitro diagnostic medical devices for human use and their accessories on the market or into service in the European Union countries are explained. This regulation also applies to performance studies conducted in European Union countries for such in-vitro diagnostic medical devices and accessories.
This regulation also repeals the directive 98/79/EC and the Commission decision no 2010/227/EU.
The following are not covered by this Regulation:
Significant impacts of in-vitro medical devices regulation include greater transparency, expanded coverage, increased surveillance, higher traceability, stricter requirements and analytical performance and scientific validity.
In short, a device under IVDR EU 2017/746 can only be put on the market or put into service if it complies with this legal regulation if it is duly procured and properly installed, maintained and used in accordance with its intended use. Such a device must meet the general safety and performance requirements set out in the said regulatory annex.
IVDR classification also takes into account the public health risk. In general, the IVDR classification includes the following four risk classes based on both patient and community health risks:
Our organization, among the numerous test, measurement, analysis and evaluation studies it provides for businesses in various sectors, also provides medical testing services within the scope of EU 2017/746 IVDR (in-vitro medical devices regulation) with its trained and expert staff and advanced technological equipment.